Evidence map›Paper›PMID 25609412›Full record

ArticleAnnals of the rheumatic diseases2016

Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration.

Iris Navarro-Millán, Shuo Yang, Scott L DuVall, Lang Chen, John Baddley, Grant W Cannon, Elizabeth S Delzell, Jie Zhang, Monika M Safford, Nivedita M Patkar and 3 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03821090 (A Study in Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis), which is not on this map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03821090 completednot on this mapstarted 2019, after this paper: background citation

A Study in Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis

TypeobservationalSponsorAssiut UniversityRan2019 to 2021Enrolled160ConditionsRheumatoid Arthritis
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Iris Navarro-MillánBirmingham VA Medical Center, Birmingham, Alabama, USA University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
Shuo YangBirmingham VA Medical Center, Birmingham, Alabama, USA University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
Scott L DuVallVA Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, Utah, USA.
Lang ChenBirmingham VA Medical Center, Birmingham, Alabama, USA University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
John BaddleyBirmingham VA Medical Center, Birmingham, Alabama, USA University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
Grant W CannonVA Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, Utah, USA.
Elizabeth S DelzellUniversity of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
Jie ZhangUniversity of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
Monika M SaffordUniversity of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
Nivedita M PatkarUniversity of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
Ted R MikulsOmaha VA and University of Nebraska Medical Center, Omaha, Nebraska, USA.
Jasvinder A SinghBirmingham VA Medical Center, Birmingham, Alabama, USA University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
Jeffrey R CurtisBirmingham VA Medical Center, Birmingham, Alabama, USA University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
University of Alabama at Birmingham · USOmaha VA Medical Center · US

Funding

Longitudinal Comparative Effectiveness & Safety of Biologics in AutoimmunityR01HS018517 · AHRQ · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURTIS, JEFFREY R. · 2009 to 2013
$2.2M
Dissection of the ACPA response in African-Americans with Rheumatoid ArthritisR01AR062376 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRIDGES, S LOUIS · 2011 to 2014
$1.7M
Ethnic Differences in the Risk of Fracture and Vascular DiseaseK23AR053351 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURTIS, JEFFREY R. · 2007 to 2011
$755k
AHRQ HHS R01 HS018517NIAMS NIH HHS K23 AR053351NIAMS NIH HHS R01 AR062376
6 · The paper itself

Abstract

objectiveTo examine the association of serum lipids, inflammation and seropositivity on coronary heart disease (CHD) and stroke in patients with rheumatoid arthritis (RA).

methodsThe incidence of hospitalised myocardial infarction (MI) or stroke was calculated in a cohort of patients with RA receiving care within the national Veterans Health Administration from 1998 to 2011. Cox proportional hazard models were used to examine the association between these outcomes and low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), C reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as time-varying variables, divided into quintiles.

resultsThere were 37,568 patients with RA in the cohort with mean age of 63 years (SD 12.1); 90% were men. There was a no clear association between LDL-C and CHD/stroke. Compared with lower HDL-C (<34 mg/dL), higher HDL-C (≥54 mg/dL) was inversely associated with MI (hazard ratio (HR)=0.68, 95% CI 0.55 to 0.85) and stroke (HR=0.69, 95% CI 0.50 to 0.96). Higher CRP >2.17 mg/dL (vs CRP <0.26 mg/dL) was associated with increased risk (HR=2.43, 95% CI 1.77 to 3.33) for MI and 2.02 (95% CI 1.32 to 3.08) for stroke. ESR >47 mm/h compared with <8 mm/h had an HR 1.87 (95% CI 1.39 to 2.52) for MI and 2.00 (95% CI 1.26 to 3.18) for stroke. The association between MI was significant for RA seropositivity (HR=1.23, 95% CI 1.03 to 1.48).

conclusionsIn this predominantly older male RA cohort, there was no clear association between LDL-C and CHD, whereas higher HDL-C was inversely associated with MI and stroke. CRP and ESR were similarly associated with increase MI risk and stroke, reflecting the prominent role of inflammation in CHD risk in RA.

Indexed as

AgedArthritis, RheumatoidBlood SedimentationCholesterol, HDLCholesterol, LDLCoronary DiseaseC-Reactive ProteinFemaleHumansHyperlipidemiasIncidenceInflammationMaleMiddle AgedMyocardial InfarctionProportional Hazards ModelsCholesterol, HDLCholesterol, LDLC-Reactive ProteinCardiovascular DiseaseInflammationRheumatoid Arthritis

Identifiers

PMID25609412
PMCPMC4752663
OpenAlexW2096178422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.